EDIRNA logo

EDIRNA

Pioneering RNA-Editing technology to create breakthrough therapeutics for untreatable conditions

11-50 employees · est. 2022

VS
Marinomed Biotech AG logo

Marinomed Biotech AG

Innovative therapies and unique solutions - an ocean of ideas

41 employees · est. 2006 · Korneuburg, Austria

Marinomed Biotech AG is the older company (2022 vs 2006).

Side-by-Side Comparison

EDIRNA Marinomed Biotech AG
Founded
2022 2006 older
Headquarters
Not tracked yet Korneuburg, Austria
Employees
11-50 41
Industry
Biotechnology Biopharma, Biotechnology, Design
Funding Stage
Corporate Round Convertible Note
Total Funding
Not tracked yet $6.61M
Funding Rounds
1 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
RNA-Editing, Biotech, Therapeutics, Undruggable Targets, Innovative Technology, Medical Breakthrough, Edit-to-Cure, Research And Development, Genetic Medicine, Biomedical Innovation Biopharmaceutical Development, Patent-Protected Technology, Innovative Therapies, Respiratory Viral Infections, Formulation Development, Drug Delivery, Virology, Immunology, Austrian Company, Therapeutics, OTC Products, Marinosolv® Technology, Carragelose®, Vienna Stock Exchange
Website
edirna.us marinomed.com
EDIRNA logo

About EDIRNA

EDIRNA is an innovative biotech company founded in 2022 with the mission of pioneering RNA-Editing technology to create breakthrough therapeutics for untreatable conditions. With a focus on the biotechnology industry, the company is dedicated to discovering and developing edit-to-cure therapeutics f...

Marinomed Biotech AG logo

About Marinomed Biotech AG

Marinomed Biotech AG is an Austrian, science-based biotech company focused on innovative therapies and unique solutions in the fields of immunology and virology. The company's development pipeline and globally marketed therapeutics are based on the Marinosolv® technology and the virus-blocking activ...

We will tell you when either one moves

BounceWatch watches EDIRNA and Marinomed Biotech AG for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EDIRNA and Marinomed Biotech AG — by email.

Frequently Asked Questions

EDIRNA — Pioneering RNA-Editing technology to create breakthrough therapeutics for untreatable conditions. Marinomed Biotech AG — Innovative therapies and unique solutions - an ocean of ideas. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EDIRNA has raised undisclosed funding while Marinomed Biotech AG has raised $6.61M.
EDIRNA and Marinomed Biotech AG operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EDIRNA with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EDIRNA on 13 Sep 2024, and Marinomed Biotech AG on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes